Gentherm's Q4 2021 product revenues decreased by 14.1% compared to the prior-year period, with automotive revenues down 15.1%. Despite these challenges, the company secured approximately $540 million in new automotive business awards and repurchased $20 million of its stock. Medical revenue increased 16.7% year over year, primarily as a result of higher Blanketrol® sales globally.
Product revenues decreased 14.1% year over year.
Automotive revenues decreased 15.1% year over year.
GAAP diluted earnings per share was $0.60 as compared with earnings per share of $1.02 for the prior-year period.
Secured new automotive business awards totaling approximately $540 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance